ANDAORALSOLUTION
Lifecycle
Pre-Launch
Clinical Trials
20
Clinical Trials (5)
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
Started Dec 2018
100 enrolled
Alzheimer's Disease
NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.
Started May 2016
118 enrolled
Mild to Moderate Alzheimer's Disease
Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
Started Feb 2014
70 enrolled
Alzheimer's Disease
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Started Aug 2012
121 enrolled
Alzheimer's Dementia
Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
Started Jul 2012
216 enrolled
Alzheimer's Disease